Zap your memory? scalp stimulation trial aims to fight forgetfulness
NCT ID NCT05289804
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a non-invasive electrical stimulation device on the scalp in 80 adults aged 50+ with mild cognitive impairment. Participants learned word pairs while receiving either real or sham stimulation. Their memory was tested right after, and again at 7 and 28 days. The goal was to see if the stimulation could reduce long-term forgetting.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- non-invasive electrical stimulation of the scalp
- What this could lead to
- If it works, this could point toward a simple, drug-free way to boost memory in people with mild cognitive impairment.
- What could go wrong
- This is an early-phase study with only 80 participants. The effect may be small or not last, and the stimulation might not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 1/2
Runs two stages together: safety and dose first, then whether the treatment works.
- Participants
-
80 people
The number who actually took part.
- Started
-
Sep 2022
- Finished
-
Jan 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
50 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * ≥50 years * Diagnosis of probable aMCI or mild AD * Montreal Cognitive Assessment between 18-25 * Mini Mental State Examination score \>21 * Stable AChl medication \>3 months * Adequate visual and auditory acuity * Capacity to understand and sign informed consent Exclusion Criteria: * Any cause of cognitive decline or dementia that is not Alzheimer's disease related including parkinsonism related dementias, vascular dementia, fronto-temporal dementia. * Enrolment in an ongoing investigational medicinal product study * History in the past 2 years of epileptic seizures * Any current major psychiatric disorder * Evidence of brain damage, including significant trauma, stroke, hydrocephalus, intellectual disability, or serious neurological disorder. * History of alcoholism or drug abuse within the last 12 months * Medical devices not eligible for MRI scanning
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Memory disorders in old age are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
TCIN
Dublin, Dublin 2, Ireland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Walking memory tests may reveal early Parkinson's clues
- Can tango rewire the brain? dance program tested for Parkinson's and dementia
- Can tiny bursts of baduanjin exercise sharpen a fading memory?
- Can pool workouts plus brain games sharpen memory in aging veterans?
- Can home exercise keep older adults with cognitive frailty on their feet?
- A new roadmap to predict Alzheimer's before memory fails